Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan R George

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 4, 2015
Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivationMaurice Y F Shen, Melissa L Perreault, Francis R Bambico, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2006
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatumAsim J Rashid, Christopher H So, Michael M C Kong, et al.
Clinical Endocrinology|April 17, 2014
Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndromeEvelyn Ning Man Cheung, Susan R George, Gary A Costain, et al.
The Journal of Biological Chemistry|December 3, 2003
Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptorsDennis K Lee, A José Lança, Regina Cheng, et al.
Biology of Sex Differences|February 24, 2020
Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviorsAhmed Hasbi, Tuan Nguyen, Haneen Rahal, et al.
Psychopharmacology|June 4, 2008
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonistSridhar Natesan, Greg E Reckless, Karen B L Barlow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2003
Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivoSusan R George, Gordon Y K Ng, Samuel P Lee, et al.
Molecular Pharmacology|June 1, 2005
D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptorChristopher H So, George Varghese, Kevin J Curley, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2016
Disruption of a dopamine receptor complex amplifies the actions of cocaineMelissa L Perreault, Ahmed Hasbi, Maurice Y F Shen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 27, 2014
A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonismAhmed Hasbi, Melissa L Perreault, Maurice Y F Shen, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 4, 2015
Rapid anti-depressant and anxiolytic actions following dopamine D1-D2 receptor heteromer inactivationMaurice Y F Shen, Melissa L Perreault, Francis R Bambico, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2006
D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatumAsim J Rashid, Christopher H So, Michael M C Kong, et al.
Clinical Endocrinology|April 17, 2014
Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndromeEvelyn Ning Man Cheung, Susan R George, Gary A Costain, et al.
The Journal of Biological Chemistry|December 3, 2003
Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptorsDennis K Lee, A José Lança, Regina Cheng, et al.
Biology of Sex Differences|February 24, 2020
Sex difference in dopamine D1-D2 receptor complex expression and signaling affects depression- and anxiety-like behaviorsAhmed Hasbi, Tuan Nguyen, Haneen Rahal, et al.
Psychopharmacology|June 4, 2008
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonistSridhar Natesan, Greg E Reckless, Karen B L Barlow, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2003
Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivoSusan R George, Gordon Y K Ng, Samuel P Lee, et al.
Molecular Pharmacology|June 1, 2005
D1 and D2 dopamine receptors form heterooligomers and cointernalize after selective activation of either receptorChristopher H So, George Varghese, Kevin J Curley, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 3, 2016
Disruption of a dopamine receptor complex amplifies the actions of cocaineMelissa L Perreault, Ahmed Hasbi, Maurice Y F Shen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 27, 2014
A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonismAhmed Hasbi, Melissa L Perreault, Maurice Y F Shen, et al.
Pageof 10